(FMT), a treatment aiming to restore dysbiosis by transferring stool from a healthy donor into
the patient, has cure rates up to 90% in the management of recurrent Clostridium difficile (C. …

Background and Aims Vedolizumab is an IgG1 anti-α4β7 integrin antibody approved for the
treatment of inflammatory bowel diseases [IBD], but without clear safety data during …

… /B] were included. Cohort A had more trough level [TL] measurements compared with cohort
B [… After 1 year, no difference was seen between cohort A and cohort B in IFX failure [19% vs …

Inflammatory bowel disease (IBD) is associated with several extra-intestinal complications,
including venous thromboembolism (VTE). In patients with IBD, VTE occurs at younger age …

… (B) Device preference according to order of presentation 2 weeks after the injections. (C)
Device preference at week 2 according to preference immediately after the injections. (D) …

WHIM syndrome is a rare congenital immunodeficiency disease, named after its main clinical
manifestations: warts, hypogammaglobulinemia, infections, and myelokathexis, which …

An immunocompetent patient without a history of recent travel or animal exposure developed
persistent abdominal bloating and cramps without diarrhoea or fever. Negative additional …

… causes of cholestasis and liver diseases (including sclerosing cholangitis, alfa1-antitrypsin
deficiency, cystic fibrosis, autoimmune hepatitis, Wilson disease, chronic hepatitis C and B, …

… (B) Confusion matrix of the training and validation set of the UC cohort with the complementary
area under the receiver operator curve (AUROC) obtained with elastic net regularized …

… Figure 6b shows the density distribution of the particle worldlines corresponding to the close
up in Figure 6a, again only for contributions from the left slit. Additionally, Figure 6d shows …